Skip to main content
SpringerLink
Log in

Giant Cell Arteritis

  • Chapter
  • First Online:
Vasculitis in Clinical Practice

  • 914 Accesses

Abstract

Giant cell arteritis is the most common form of systemic vasculitis in the elderly. It is characterized by the involvement of the large vessels, predominantly the extracranial branches of the aorta. There is a close relationship with polymyalgia rheumatica (PMR).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994;37:187-192.

    Article  PubMed  CAS  Google Scholar 

  2. Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33:1122-1128.

    Article  PubMed  CAS  Google Scholar 

  3. Mazlumzadeh M, Hunder GG, Easley KA, et al. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo controlled, randomised prospective clinical trial. Arthritis Rheum. 2006;54:3310-3318.

    Article  PubMed  CAS  Google Scholar 

  4. Mukhtyar C, Guillevin L, Cid MC, et al. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2009;68:318-323.

    Article  PubMed  CAS  Google Scholar 

  5. Mahr AD, Jover JA, Spiera RF, et al. Adjunctive methotrexate for treatment of giant cell arteritis. Arthritis Rheum. 2007;56:2789-2797.

    Article  PubMed  CAS  Google Scholar 

  6. Salvarani C, Macchioni P, Manzini C, et al. Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial. Ann Intern Med. 2007;146:631-639.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Rheumatology, Ipswich Hospital, Heath Road, Ipswich, UK

    Richard A. Watts MD FRCP

  2. School of Medicine Health Policy and Practice, University of East Anglia, Norwich, UK

    Richard A. Watts MD FRCP

  3. Department of Rheumatology Norfolk and Norwich, University Hospital Foundation University of East Anglia School of Medicine Health Policy and Practice, Norwich, UK

    David G. I. Scott MA DM FRCP

Authors
  1. Richard A. Watts MD FRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David G. I. Scott MA DM FRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Ipswich Hospital, Dept. Rheumatology, NHS Trust, Heath Road, Ipswich, IP4 5PD, United Kingdom

    Richard A. Watts

  2. Dept. Rheumatology, Norfolk & Norwich University Hospital, Colney Lane, Norwich, NR4 7UY, United Kingdom

    David G. I. Scott

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag London Limited

About this chapter

Cite this chapter

Watts, R.A., Scott, D.G.I. (2010). Giant Cell Arteritis. In: Watts, R., Scott, D. (eds) Vasculitis in Clinical Practice. Springer, London. https://doi.org/10.1007/978-1-84996-247-6_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-84996-247-6_5

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84996-246-9

  • Online ISBN: 978-1-84996-247-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation